Sunfox Technologies raises $7M to scale cardiac diagnostics platform

Sunfox Technologies, a Dehradun-based medtech startup, has secured $7 million in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital. The company plans to use the funds to scale its cardiac diagnostics platform, Spandan, and expand its reach across India and global markets.

Funding and Growth Plans

Sunfox Technologies, a Dehradun-based medtech company, has raised $7 million in a Series A funding round. The round was led by investors including Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital, according to YourStory.

The company plans to use the fresh capital to scale its cardiac diagnostics platform, Spandan, and expand its presence across India. Additionally, Sunfox aims to develop regulatory, distribution, and commercial capabilities in priority international markets, including the United States and European Union.

Technology and Impact

Sunfox Technologies develops Spandan, a portfolio of ECG solutions designed for personal, clinical, and institutional settings. The platform enables suspected heart attack detection using a smartphone, with results reviewed by remote doctors around the clock.

The company’s Spandan One platform screens approximately 5 million patients annually. To date, around 60,000 Spandan devices have been deployed, including in over 20,000 villages across India.

Sunfox has secured regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa. The company is also pursuing clearances in the US and EU, which would enable further global expansion.

Founder Perspectives

Rajat Jain, Founder and CEO of Sunfox Technologies, stated that this funding round provides the resources to elevate the company’s Dehradun-built technology to a larger stage. He emphasized the company’s commitment to investing in R&D while expanding across India and building capabilities for global markets.

Jain also highlighted the long-term vision of taking Sunfox and its Spandan platform to international markets, leveraging the company’s existing regulatory and operational foundations.

Background

Sunfox Technologies was founded in 2016 by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola, and Saurabh Badola. The company focuses on developing accessible cardiac diagnostics solutions, particularly for underserved regions.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

Sunfox Technologies’ $7 million Series A is a signal that cardiac diagnostics is gaining traction as a scalable, tech-driven solution—especially in markets where access to traditional healthcare infrastructure is limited. For founders, this round highlights two key opportunities:

1. Localized Innovation with Global Potential: Sunfox’s success in rural India demonstrates that solving hyper-local challenges—like remote cardiac care—can create a blueprint for broader markets, including the US and EU. The focus on regulatory compliance early in the expansion plan is a smart move; founders eyeing global markets should prioritize this from day one.

2. Investor Appetite for Healthtech: The participation of high-profile investors like Ashish Kacholia and 3one4 Capital underscores growing interest in healthtech startups that combine hardware, software, and scalable service models. For operators, this means there’s room to innovate beyond pure software—especially in areas like diagnostics, where hardware-enabled solutions can address critical gaps in underserved regions.

Key takeaways

• Sunfox Technologies raised $7 million in a Series A round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital.
• The company will use the funds to scale its cardiac diagnostics platform, Spandan, and expand across India and global markets.
• Spandan ECG solutions are deployed in over 20,000 villages, screening around 5 million patients annually.
• Sunfox has regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa, and is pursuing clearances in the US and EU.

FAQ

What is Sunfox Technologies?

Sunfox Technologies is a Dehradun-based medtech company focused on developing cardiac diagnostics solutions, including the Spandan ECG platform.

How much funding did Sunfox Technologies raise?

Sunfox Technologies raised $7 million in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital.

What will Sunfox Technologies use the funds for?

The funds will be used to scale the Spandan cardiac diagnostics platform, expand across India, and develop capabilities for global markets, including the US and EU.

Where is Sunfox Technologies’ technology currently deployed?

Sunfox’s Spandan ECG solutions are deployed in over 20,000 villages across India, screening approximately 5 million patients annually.

Which markets has Sunfox Technologies received regulatory approvals in?

Sunfox Technologies has regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa. It is also pursuing clearances in the US and EU.

Related on Lazyfounder

• More startup news